Will Sam Altman beat death? ChatGPT creator backs anti-ageing research startup
Sam Altman invests $180 million in Retro Biosciences a start up that aims at achieving life longevity.
Source: digit.in
Stay updated with breaking news from Ife Span Longevity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sam Altman invests $180 million in Retro Biosciences a start up that aims at achieving life longevity.